(ICL) ICL Israel Chemicals - Overview
Stock: Potash, Bromine, Phosphates, Fertilizers, Flame Retardants
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.81% |
| Yield on Cost 5y | 4.57% |
| Yield CAGR 5y | -28.45% |
| Payout Consistency | 72.3% |
| Payout Ratio | 62.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.4% |
| Relative Tail Risk | -8.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.05 |
| Alpha | -17.67 |
| Character TTM | |
|---|---|
| Beta | 0.669 |
| Beta Downside | 0.694 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.57% |
| CAGR/Max DD | -0.13 |
Description: ICL ICL Israel Chemicals January 06, 2026
ICL Group Ltd (NYSE:ICL) is a diversified specialty minerals and chemicals producer operating worldwide through four business segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products line extracts bromine from potash by-products and manufactures bromine-based compounds, while the Potash segment supplies potash, salt, magnesium chloride, magnesia, and related by-products such as chlorine and sylvinite. The Phosphate Solutions segment converts raw phosphate into specialty fertilizers, green phosphoric acid, and functional food ingredients. Growing Solutions focuses on nitrogen-based, water-soluble, controlled-release, and bio-stimulant fertilizers, plus digital agronomy platforms.
The company serves a broad customer base across pharmaceuticals, food, oil & gas, de-icing, construction, oral care, paints & coatings, water treatment, electronics, automotive, textiles, tire manufacturing, healthcare, power generation, and battery production. Sales are channeled through a network of marketing companies, agents, and distributors, giving ICL a global reach despite its Israeli headquarters.
Key recent metrics: FY 2023 revenue reached approximately $6.3 billion with an adjusted EBITDA margin near 10 %, reflecting strong pricing power in the potash market (average spot price ≈ $380 / tonne in 2023). Demand drivers include rising global grain production, especially in Brazil and the U.S. Midwest, and the ongoing ESG shift toward higher-efficiency, low-phosphorus fertilizers. ICL’s exposure to electricity generation and battery-grade magnesium positions it to benefit from the accelerating energy transition.
For a deeper quantitative view, check ValueRay’s analyst dashboard for ICL’s valuation multiples and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 369.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.73 > 1.0 |
| NWC/Revenue: 17.38% < 20% (prev 19.83%; Δ -2.44% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.16b > Net Income 369.0m |
| Net Debt (2.33b) to EBITDA (1.33b): 1.74 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.29b) vs 12m ago 0.08% < -2% |
| Gross Margin: 31.94% > 18% (prev 0.33%; Δ 3161 % > 0.5%) |
| Asset Turnover: 59.22% > 50% (prev 59.96%; Δ -0.74% > 0%) |
| Interest Coverage Ratio: 3.71 > 6 (EBITDA TTM 1.33b / Interest Expense TTM 221.0m) |
Altman Z'' 3.79
| A: 0.10 (Total Current Assets 4.05b - Total Current Liabilities 2.82b) / Total Assets 12.26b |
| B: 0.48 (Retained Earnings 5.91b / Total Assets 12.26b) |
| C: 0.07 (EBIT TTM 821.0m / Avg Total Assets 11.91b) |
| D: 1.05 (Book Value of Equity 6.15b / Total Liabilities 5.88b) |
| Altman-Z'' Score: 3.79 = AA |
Beneish M -3.19
| DSRI: 0.80 (Receivables 1.42b/1.73b, Revenue 7.05b/6.93b) |
| GMI: 1.03 (GM 31.94% / 32.91%) |
| AQI: 1.04 (AQ_t 0.12 / AQ_t-1 0.11) |
| SGI: 1.02 (Revenue 7.05b / 6.93b) |
| TATA: -0.06 (NI 369.0m - CFO 1.16b) / TA 12.26b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of ICL shares?
Over the past week, the price has changed by +2.43%, over one month by -1.44%, over three months by -2.85% and over the past year by -6.79%.
Is ICL a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ICL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.2 | 13.5% |
| Analysts Target Price | 6.2 | 13.5% |
| ValueRay Target Price | 5.5 | 0.9% |
ICL Fundamental Data Overview February 03, 2026
P/S = 0.979
P/B = 1.151
P/EG = 9.44
Revenue TTM = 7.05b USD
EBIT TTM = 821.0m USD
EBITDA TTM = 1.33b USD
Long Term Debt = 1.89b USD (from longTermDebt, last quarter)
Short Term Debt = 787.0m USD (from shortTermDebt, last quarter)
Debt = 2.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 9.11b USD (6.91b + Debt 2.68b - CCE 476.0m)
Interest Coverage Ratio = 3.71 (Ebit TTM 821.0m / Interest Expense TTM 221.0m)
EV/FCF = 28.75x (Enterprise Value 9.11b / FCF TTM 316.9m)
FCF Yield = 3.48% (FCF TTM 316.9m / Enterprise Value 9.11b)
FCF Margin = 4.49% (FCF TTM 316.9m / Revenue TTM 7.05b)
Net Margin = 5.23% (Net Income TTM 369.0m / Revenue TTM 7.05b)
Gross Margin = 31.94% ((Revenue TTM 7.05b - Cost of Revenue TTM 4.80b) / Revenue TTM)
Gross Margin QoQ = 32.60% (prev 30.24%)
Tobins Q-Ratio = 0.74 (Enterprise Value 9.11b / Total Assets 12.26b)
Interest Expense / Debt = 1.68% (Interest Expense 45.0m / Debt 2.68b)
Taxrate = 30.65% (57.0m / 186.0m)
NOPAT = 569.4m (EBIT 821.0m * (1 - 30.65%))
Current Ratio = 1.43 (Total Current Assets 4.05b / Total Current Liabilities 2.82b)
Debt / Equity = 0.44 (Debt 2.68b / totalStockholderEquity, last quarter 6.13b)
Debt / EBITDA = 1.74 (Net Debt 2.33b / EBITDA 1.33b)
Debt / FCF = 7.34 (Net Debt 2.33b / FCF TTM 316.9m)
Total Stockholder Equity = 5.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.10% (Net Income 369.0m / Total Assets 12.26b)
RoE = 6.22% (Net Income TTM 369.0m / Total Stockholder Equity 5.93b)
RoCE = 10.49% (EBIT 821.0m / Capital Employed (Equity 5.93b + L.T.Debt 1.89b))
RoIC = 6.75% (NOPAT 569.4m / Invested Capital 8.44b)
WACC = 6.36% (E(6.91b)/V(9.59b) * Re(8.38%) + D(2.68b)/V(9.59b) * Rd(1.68%) * (1-Tc(0.31)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.03%
[DCF Debug] Terminal Value 81.42% ; FCFF base≈482.1m ; Y1≈381.7m ; Y5≈253.2m
Fair Price DCF = 3.46 (EV 6.79b - Net Debt 2.33b = Equity 4.47b / Shares 1.29b; r=6.36% [WACC]; 5y FCF grow -24.89% → 2.90% )
EPS Correlation: -84.03 | EPS CAGR: -64.69% | SUE: -4.0 | # QB: 0
Revenue Correlation: -74.17 | Revenue CAGR: -2.51% | SUE: 1.95 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.44 | Chg30d=+0.008 | Revisions Net=+1 | Growth EPS=+21.8% | Growth Revenue=+4.9%